April 1, 2025 - 10:25

Anixa Biosciences, Inc., a biotechnology firm dedicated to advancing cancer treatment and prevention, is set to present at the upcoming Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th. This event will gather industry leaders, investors, and innovators to discuss the latest advancements in healthcare technology.
The company is recognized for its groundbreaking work in developing novel therapies aimed at combating various forms of cancer. Anixa's commitment to innovation is evident in its ongoing research and development efforts, which focus on harnessing the body’s immune system to fight cancer more effectively.
Attendees at the conference can expect to gain insights into Anixa’s latest projects and strategic vision for the future. The presentation will highlight the company's progress and its potential impact on the healthcare landscape. As the demand for effective cancer treatments continues to grow, Anixa Biosciences is positioning itself as a key player in the biotechnology sector.
May 22, 2026 - 07:29
WVDOT wins award for use of GIS technologyThe West Virginia Department of Transportation has received a Special Achievement in GIS Award from Esri, a leading geographic information system company. The award recognizes the department`s work...
May 21, 2026 - 18:41
Analog Devices to Participate in the Bank of America Global Technology ConferenceAnalog Devices, Inc. (ADI) confirmed today that its Executive Vice President and Chief Financial Officer, Richard Puccio, will be a featured speaker at the upcoming Bank of America Global...
May 21, 2026 - 04:21
This Quantum Player Just Went Public. It’s Already Launching Technology Into Space.Infleqtion, a quantum technology company that just completed its public listing, is already preparing to send its hardware beyond Earth`s atmosphere. CEO Matt Kinsella sees a massive market...
May 20, 2026 - 12:19
Mohnish Pabrai Says Technology Is Overrated In InvestingArtificial intelligence, venture capital optimism, and the pursuit of rapid financial outcomes continue to dominate investor thinking. Across both public and private markets, capital is...